Japan's Takeda Pharmaceutical nabbed European approval for its treatment for ulcerative colitis and Crohn's disease, Entyvio, after winning the FDA's blessing last week. Report
Japan's Takeda Pharmaceutical nabbed European approval for its treatment for ulcerative colitis and Crohn's disease, Entyvio, after winning the FDA's blessing last week. Report